ABIOMED Announces First European Site for AbioCor Implantable Replacement Heart Clinical Trial
ABIOMED, Inc. (NASDAQ:ABMD) today announced that the North Rhine-Westphalia Heart Center, Bad Oeynhausen, Germany will serve as a European clinical trial site […]